EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Lactylation Modification: From Basic Biological Process to Clinical Cardiovascular Diseases

Jilong Geng, Zheyan Fang, Zhentao Zhang, Junbo Ge, Hua Li iD

Research · 01.01.2026 · 9

DOI: 10.34133/research.1228 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research, online erschienen am 03.04.2026. Verfasst von Jilong Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and are hallmarked by profound disturbances in energy metabolism and maladaptive tissue remodeling. Lactate, long dismissed as a metabolic waste product, is now recognized as a context-dependent central carbon source and signaling metabolite. A key recent advance is the discovery of lysine lactylation (Kla), an evolutionarily conserved posttranslational modification that couples lactate abundance to chromatin state and protein function. Here, we synthesize current knowledge on the biogenesis and enzymatic regulation of Kla, and delineate how lactate-driven histone and nonhistone lactylation remodel transcriptional and signaling networks controlling fibrosis, energy metabolism, immune and inflammatory responses, and angiogenesis. We then focus on emerging evidence that Kla is a nodal regulator across major cardiovascular pathologies—including atherosclerosis, myocardial infarction and ischemia/reperfusion injury, heart failure, valvular and arterial calcification, and pulmonary hypertension—where it can act as a context-dependent “accelerator” or “brake” of disease progression. Finally, we outline a translational framework that targets the lactate–lactylation axis at 3 levels: lactate transport, lactate production, and lactylation writers/erasers, highlighting opportunities and challenges for therapeutic intervention. Together, these insights position protein lactylation as a pivotal metabolic–epigenetic interface in the cardiovascular system and a promising entry point for precision therapies in CVDs.

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China.
  • State Key Laboratory of Cardiology, Shanghai 200032, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
  • Shanghai Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
  • Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai 200032, China.

ORCID-Profile: Hua Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Geng, J., Fang, Z., Zhang, Z., Ge, J., & Li, H. (2026). Lactylation Modification: From Basic Biological Process to Clinical Cardiovascular Diseases. Research, 9. https://doi.org/10.34133/research.1228

Vancouver

Geng J, Fang Z, Zhang Z, Ge J, Li H. Lactylation Modification: From Basic Biological Process to Clinical Cardiovascular Diseases. Research. 2026;9. doi:10.34133/research.1228

BibTeX
@article{Geng2026,
  author = {Geng, Jilong and Fang, Zheyan and Zhang, Zhentao and Ge, Junbo and Li, Hua},
  title = {Lactylation Modification: From Basic Biological Process to Clinical Cardiovascular Diseases},
  journal = {Research},
  year = {2026},
  volume = {9},
  doi = {10.34133/research.1228}
}
Kostenlos starten →